GenMark Diagnostics (GNMK) – Corporate News
-
Roche to acquire GenMark Diagnostics (GNMK) for $24.05/Share
-
GenMark Diagnostics (GNMK) ePlex RP2 Panel Predicted to Detect Known SARS-CoV-2 Variants Currently in Circulation Based on in silico Analysis
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to GNMK Stock Lookup